In stock COA-25%
In stock COA DOCUMENT SLOT-25%
Recovery ResearchBPC-157
Pentadecapeptide isolated from human gastric juice, widely studied in preclinical tissue-repair and cytoprotection models.
Research catalogueLaboratory-use positioning
Batch documentationBatch certificate supplied with order
Order trackingFrom payment to dispatch
Product information
CompoundBPC-157
Presentation5mg vial
CategoryRecovery Research
AvailabilityIn stock
Batch COACertificate supplied with order
You save €29.90 on this presentation — an extra 10% off when you pay with crypto.
For research use only. Not for human consumption, diagnostic, therapeutic or veterinary use.
Overview
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It consists of 15 amino acids and has been the subject of extensive preclinical research since the 1990s. Studies have investigated its effects on tissue repair, angiogenesis, and gastrointestinal cytoprotection across multiple animal models. BPC-157 has demonstrated stability in human gastric juice, distinguishing it from many other peptides that degrade rapidly in acidic environments.
Mechanism of Action
BPC-157 is believed to exert its effects through modulation of the nitric oxide (NO) system and interaction with the FAK-paxillin pathway, promoting endothelial cell migration and angiogenesis. Research suggests it may also influence the expression of growth factors including EGF, VEGF, and FGF, and interact with the dopaminergic and serotonergic systems. Its cytoprotective properties have been linked to upregulation of the GABAergic system and modulation of prostaglandin pathways.
Research Applications
- Gastrointestinal cytoprotection and mucosal integrity research
- Tendon, ligament, and muscle repair models
- Angiogenesis and wound healing studies
- Nitric oxide system modulation research
- Neuroprotective pathway investigation
FREE TOOL
Reconstitution calculator
Enter your reconstitution to get the draw volume for BPC-157.
Concentration2.50 mg/ml
Draw volume0.100 ml
On the syringe10.0 units
Doses per vial20
10units
Pull the plunger to 10.0 units on a 1 ml U‑100 syringe0.100 ml · 2.50 mg/ml · 20 doses per vial
Concentration = peptide mass ÷ water volume. Unit readings assume U-100 insulin syringes, graduated 100 units per millilitre. For laboratory calculation only — not dosing guidance.